The reported down-regulation of EGFR in GBM tumors, together with the ability to regulate oncogenic EGFR signaling in glioma cell lines, suggests the therapeutic potential of hUCBSC in regulating GBM tumors. The gene discussed is EGFR; the disease is central nervous system cancer.